Chemistry: molecular biology and microbiology – Apparatus – Including condition or time responsive control means
Reexamination Certificate
2001-01-25
2002-10-08
Beisner, William H. (Department: 1744)
Chemistry: molecular biology and microbiology
Apparatus
Including condition or time responsive control means
C435S029000, C435S032000, C435S287300, C435S307100
Reexamination Certificate
active
06461860
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is related in general to apparatus for aligning the microelectrodes of a voltage-clamp perfusion chamber with a target oocyte and, in particular, to an alignment mechanism suitable for automated, repeatable implementation while measuring in parallel electrophysiological responses from multiple frog oocytes in sequential experiments.
2. Description of the Related Art
As detailed in commonly-owned copending application Ser. No. 09/586,633, herein incorporated by reference in its entirety, the normal process of drug discovery involves a number of distinct stages from the initial identification of a potentially useful substance to the final step of clinical testing. Multiple screening steps are necessary to isolate substances of interest from libraries of potentially useful compounds.
The explosion of data made available from genetic research coupled with advances in chemical synthesis has produced a great demand for ever-higher screening rates to test potentially therapeutic compounds. Thus, the ability to screen compound libraries at higher and higher throughput is becoming increasingly critical in the search for new drugs, which is now a large-scale industrial activity. Accordingly, there is a growing need for integrated laboratory systems that assess large numbers of compounds quickly.
Of particular relevance to the present invention are assays conducted on Xenopus frog oocytes, which are uniquely suitable for screening of ion channels linked to a variety of diseases. Using conventional voltage clamping across the membrane of the oocyte, the voltage dependence of ion channel activity in the oocyte cell is assessed by measuring current changes produced in response to exposure to multiple test solutions. Testing of an oocyte cell under voltage-clamped conditions, a technique that is well known in the art, is carried out in batch operations in a chamber designed to support an individual oocyte being perfused with a test solution. The cell membrane is pierced with two microelectrodes of a voltage-clamp amplifier capable of recording current variations in response to voltage step changes or to the application of compounds under constant-voltage conditions.
A conventional two-electrode voltage-clamp system
10
is illustrated schematically in
FIG. 1
, where numerals
12
and
14
refer to a voltage-recording microelectrode and a current-passing microelectrode, respectively, inserted through the membrane
16
of an oocyte cell C. The membrane potential V
m
is recorded by a unit-gain buffer amplifier
18
connected to the microelectrode
12
. The membrane potential V
m
is compared to a control potential V
c
in a high-gain differential amplifier
20
(with gain &mgr;) producing a voltage output V
&egr;
proportional to the difference &egr; between V
m
and V
c
. The voltage V
&egr;
at the output of the differential amplifier
20
forces current to flow through the current-passing microelectrode
14
into the oocyte cell C, such as to drive the error &egr; to zero and maintain the membrane voltage clamped at V
c
. The circuit is completed through a ground
22
across the cell membrane, which in the schematic drawing is modeled by impedance and capacitance values R
m
and C
m
, respectively.
One of the main concerns in designing perfusion chambers for oocytes is the ability to isolate the oocyte cell in a stationary condition, so that it can be contacted by the voltage-clamp microelectrodes and exposed to the test solution of interest. U.S. Ser. No. 09/586,633 describes a perfusion chamber design characterized by a porous oocyte support structure with a sloped top surface that produces the automatic entrapment of the underside of the oocyte, thereby localizing the cell in a predetermined fixed position within the reach of dedicated voltage-clamp microelectrodes. The test solution is delivered continuously at the top of the chamber, above the oocyte, and withdrawn from the bottom of the chamber, below the oocyte. The porosity of the support material enables the continuous perfusion of test solution around the membrane of the oocyte, including its bottom portion that is firmly in place within the holding well. The geometry of the holding well is judiciously selected, as a function of the specific oocyte or other cell being tested, to ensure the automatic and precise placement of the cell by gravity and to optimize the pressure distribution over its membrane, thereby minimizing the probability of rupture or other damage to the cell. Once so restrained, the test cell is connected to the voltage-clamp microelectrodes and perfused with test solution in a batch operation.
The ooycyte cells C under investigation and the microelectrodes
12
,
14
of voltage-clamp apparatus are extremely small (typically about 1.0 mm to 1.5 mm in diameter, with the electrodes coming to a point about 0.12 mm wide). Therefore, the process of alignment of the oocyte positioned in the well of the perfusion chamber with the microelectrodes of the voltage-clamp apparatus involves a precise operation and is typically carried out by an operator with the aid of a microscope and a micromanipulator in individual workstations, performing one experiment at a time. Accordingly, it is not suitable for automated, higher-throughput, parallel-testing applications. Moreover, the configuration of many prior-art chambers often impedes direct access of the microelectrodes to the oocyte, thereby further complicating automatic insertion of the electrodes. Japanese Patent Bulletin No. 11-299496 (Fukusono et al.) describes a family of oocyte perfusion devices developed to solve this alignment problem in single-electrode voltage-clamp environments. The oocyte is placed in a conical chamber at the bottom of a cylindrical passage adapted for aligning the microelectrode with the oocyte. Because of the perfect alignment between the oocyte fixed to the chamber and the microelectrode, the tip of the electrode can be easily inserted into the oocyte without the aid of a microscope or micromanipulator. The insertion of the microelectrode can be effected manually or through a variety of mechanisms producing the linear motion of the electrode. Thus, the oocyte chamber serves the dual purpose of housing the oocyte and guiding a single microelectrode toward the oocyte.
While useful for facilitating the alignment of the microelectrode with the oocyte, the concept described by Fukusono et al. is not suitable for two-electrode voltage-clamp applications. Furthermore, it does not provide for the mechanical engagement and disengagement of the electrode from the alignment passage, which is critical for automated operation. Accordingly, the disclosed devices as well as other prior-art apparatus are not well suited for the high-throughput, electronically manipulated, automated-system needs of today's pharmaceutical industry. This invention provides a mechanism designed to address these needs.
BRIEF SUMMARY OF THE INVENTION
The primary objective of this invention is a voltage-clamp apparatus suitable for sequential testing of animal cells through successive exposures to multiple perfusion solutions in an automated, continuous system.
In particular, an objective of the invention is an automated alignment system for the correct placement of the voltage-clamp electrodes within the perfusion chamber, so that no microscope or other manually operated control device is used to guide the electrodes into the test cell.
A goal is also a microelectrode alignment system that permits the rapid change of an inoperative electrode without the need for recalibration of the guiding mechanism.
Another goal of the invention is a design particularly suitable for the testing of oocytes, especially
Xenopus oocytes.
Another objective is a voltage-clamp apparatus that can be adapted for parallel testing of multiple oocytes in a higher-throughput testing system.
Another goal is a voltage-clamp design that is suitable for implementation within an overall automated voltage-clamp and solution-delivery system.
Hamersly Gregory A.
Mathes Christopher W.
Axon Instruments, Inc.
Beisner William H.
Durando Antonio R.
Durando Birdwell & Janke PLC
LandOfFree
Alignment mechanism for two-electrode voltage-clamp... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alignment mechanism for two-electrode voltage-clamp..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alignment mechanism for two-electrode voltage-clamp... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3000414